Perigon Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.39M | Buy |
|
|||||
|
2025
Q2 | $2.67M | Buy |
|
|||||
|
2025
Q1 | $2.56M | Buy |
|
|||||
|
2024
Q4 | $2.06M | Buy |
|
|||||
|
2024
Q3 | $2.26M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $583K | Buy |
|
|||||
|
2023
Q3 | $495K | Sell |
|
|||||
|
2023
Q2 | $545K | Buy |
|
|||||
|
2023
Q1 | $420K | Sell |
|
|||||
|
2022
Q4 | $502K | Buy |
|
|||||
|
2022
Q3 | $461K | Sell |
|
|||||
|
2022
Q2 | $741K | Sell |
|
|||||
|
2022
Q1 | $950K | Buy |
|
|||||
|
2021
Q4 | $684K | Buy |
|
|||||
|
2021
Q3 | $484K | Sell |
|
|||||
|
2021
Q2 | $633K | Buy |
|
|||||
|
2021
Q1 | $461K | Buy |
|
|||||
|
2020
Q4 | $175K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $11K | Hold |
|
|||||
|
2017
Q4 | $10K | Hold |
|
|||||
|
2017
Q3 | $10K | Buy |
|